| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 24.05.
| Boston CEO Conference to Feature CEOs of Alkermes, Alnylam, Ariad, Biogen, Cubist, Genzyme, Millennium, Momenta, Sirtris, and Others June 11th and 12th | | 59 | Business Wire |
| More than 200 leading CEOs will gather at the 2012 CEO Conference June 11th
and 12th at the Mandarin Oriental Hotel in Boston.
The Boston CEO Conference is...
Mehr lesen zu:
Boston CEO Conference to Feature CEOs of Alkermes, Alnylam, Ariad, Biogen, Cubist, Genzyme, Millennium, Momenta, Sirtris, and Others June 11th and 12th | |
| 17.05.
| ROUNDUP: Alkermes Loss Widens; Details Weak FY Sales Outlook; Stock Down | | 36 | AFX News |
| WASHINGTON (dpa-AFX) - Biotechnology company Alkermes plc (ALKS), Thursday
reported a wider-than-expected loss for the fourth quarter, hurt mostly on
charges related to the acquisition of...
Mehr lesen zu:
ROUNDUP: Alkermes Loss Widens; Details Weak FY Sales Outlook; Stock Down | |
| 17.05.
| Alkermes takes bigger 4Q loss after Elan deal | | 4 | Yahoo-USA |
| 17.05.
| Alkermes Shares Sinking Lower, Down 6.9% | | - | SmarTrend |
| 17.05.
| Alkermes Reports Narrower-Than-Expected Loss | | - | SmarTrend |
| 17.05.
| Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for Fiscal 2013 | | 26 | Business Wire |
| — Fiscal 2012 Revenues Grew 109% Year-Over-Year to $390 Million —
— Fiscal 2012 Adjusted EBITDA Grew to $70.2 Million from an Adjusted
EBITDA Loss of $15.4...
Mehr lesen zu:
Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for Fiscal 2013 | |
| 10.05.
| Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2012 | | 31 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT
(1:30 p.m. BST) on Thursday, May 17, 2012, to discuss the company's
financial results...
Mehr lesen zu:
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2012 | |
| 03.05.
| Alkermes' Corporate Presentation to be Webcast at the R.W. Baird Growth Stock Conference | | 30 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the R.W. Baird Growth Stock Conference on
Thursday, May 10...
Mehr lesen zu:
Alkermes' Corporate Presentation to be Webcast at the R.W. Baird Growth Stock Conference | |
| 24.04.
| Alkermes Crosses Above its 10-day MA | | - | SmarTrend |
| 28.03.
| Shares of Alkermes Receive a Boost, Up 6.0% | | 2 | SmarTrend |
| 13.03.
| Elan Raises $381 Mln In Sale Of 76% Of Alkermes Holding | | 76 | AFX News |
| DUBLIN (dpa-AFX) - Irish drugmaker Elan Corporation, plc (ELN) said Tuesday
that it has raised about $381 million in net proceeds from the sale of 76%, or
24.15 million ordinary shares,...
Mehr lesen zu:
Elan Raises $381 Mln In Sale Of 76% Of Alkermes Holding | |
| 13.03.
| Elan Raises $381 Million in Sale of 76% of Alkermes Holding | | 54 | Business Wire |
| Elan Corporation, plc (NYSE: ELN) today raised approximately $381
million in net proceeds from the sale of 76% (24.15 million ordinary
shares) of its shareholding in Alkermes...
Mehr lesen zu:
Elan Raises $381 Million in Sale of 76% of Alkermes Holding | |
| 13.03.
| Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan | | 29 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) ("Alkermes") today announced the completion of an
underwritten public offering of 24,150,000 ordinary shares held by a
subsidiary of...
Mehr lesen zu:
Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan | |
| 08.03.
| Alkermes Reports Pricing Of Offering Of 21 Mln Shares Held By Elan At $16.50/shr | | 41 | AFX News |
| DUBLIN (dpa-AFX) - Alkermes plc (ALKS) announced the pricing of an
underwritten public offering of 21 million ordinary shares held by a subsidiary
of Elan Corporation, plc at a price to...
Mehr lesen zu:
Alkermes Reports Pricing Of Offering Of 21 Mln Shares Held By Elan At $16.50/shr | |
| 08.03.
| Alkermes plc Prices Secondary Offering of 21,000,000 Ordinary Shares Held by Elan | | 22 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) ("Alkermes") today announced the pricing of an
underwritten public offering of 21,000,000 ordinary shares held by a
subsidiary of Elan...
Mehr lesen zu:
Alkermes plc Prices Secondary Offering of 21,000,000 Ordinary Shares Held by Elan | |
| 07.03.
| Alkermes (ALKS) Announces 13.9M Secondary Offering by Elan (ELN) | | 1 | StreetInsider.com |
| 07.03.
| Alkermes plc Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan | | 41 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) ("Alkermes") today announced that it has
commenced an underwritten public offering, subject to market and other
conditions, of 13,900...
Mehr lesen zu:
Alkermes plc Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan | |
| 05.03.
| Alkermes Appoints Mark Stejbach as Chief Commercial Officer | | 25 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) today announced that Mark Stejbach has been
appointed Chief Commercial Officer. In this newly created role, Mr.
Stejbach will be responsible...
Mehr lesen zu:
Alkermes Appoints Mark Stejbach as Chief Commercial Officer | |
| 27.02.
| Alkermes' Corporate Presentation to be Webcast at the Cowen & Company 32nd Annual Health Care Conference | | 35 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Cowen & Company 32nd Annual
Health Care Conference on Monday...
Mehr lesen zu:
Alkermes' Corporate Presentation to be Webcast at the Cowen & Company 32nd Annual Health Care Conference | |
| 16.02.
| Alkermes Files Resale Shelf Registration in Connection with Elan Shareholder Agreement | | 70 | Business Wire |
| Alkermes
plc (NASDAQ: ALKS) today filed a resale shelf Registration Statement
on Form S-1 with the Securities and Exchange Commission ("SEC") relating
to the potential...
Mehr lesen zu:
Alkermes Files Resale Shelf Registration in Connection with Elan Shareholder Agreement | |
